The endoprosthesis market has witnessed significant growth in recent years. Endoprosthesis are used during joint replacement surgeries for conditions like arthritis to replace damaged bone and cartilage. The growing geriatric population suffering from orthopedic conditions and the increasing number of hip and knee replacement surgeries being performed globally are some of the key factors driving the demand for endoprosthesis. Advancements in 3D printing technologies have allowed manufacturers to develop customized implants with intricate designs and precise fits based on patients' anatomy, improving surgical outcomes.

The global endoprosthesis market is estimated to be valued at US$ 26.35 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period from 2024 to 2031.

Key Takeaways
Key players operating in the endoprosthesis market are NVIDIA Corporation, IBM, Microsoft, Fabric Genomics Inc., Verge Genomics, MolecularMatch Inc., SOPHiA GENETICS, PrecisionLife Ltd, BenevolentAI, and Deep Genomics.

The Endoprosthesis Market Size provides significant opportunities for players to develop innovative 3D printed implants, patient-specific devices, and smart endoprosthesis integrated with sensors. Advancements in areas of robotics, artificial intelligence, and digital technologies allow designing of implants for precise reconstruction and real-time monitoring of implant performance post-surgery.

Get More Insights on- Endoprosthesis Market